Vanguard Group Inc

13F Holdings History for Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX)

Symbol: CDLX on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001
Latest Disclosed Ownership: 2.42M shares
Security Ownership: 4.6%

Shares, Excluding Options vs Price

Value, Excluding Options

The Vanguard Group ownership in Cardlytics, Inc. Common Stock, par value $0.0001 (CDLX)

2025-07-29 - The Vanguard Group has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.42M shares of Cardlytics, Inc. Common Stock, par value $0.0001 (CDLX). This represents 4.6% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
The Vanguard Group	4.6%		$5.08M	2.42M			$2.10	13G/A	6/30/2025	29 Jul 2025 11:23:57

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0%	0%	$5.84M	2.4M	-15,473	-0.64%	$2.43	Q3 2025
6/30/2025	0%	0%	$3.98M	2.42M	-251,216	-9.42%	$1.65	Q2 2025
3/31/2025	0%	0%	$4.86M	2.67M	-23,310		$1.82	Q1 2025
12/31/2024	0%	+0%	$9.99M	2.69M	+22,620	+0.85%	$3.71	Q4 2024
9/30/2024	0%	+0%	$8.54M	2.67M	+256,266	+10.6%	$3.20	Q3 2024
6/30/2024	0%	+0%	$19.8M	2.41M	+200,954	+9.09%	$8.21	Q2 2024
3/31/2024	0%	+0%	$32M	2.21M	+57,805	+2.68%	$14.49	Q1 2024
12/31/2023	0%	+0%	$19.8M	2.15M	+142,085	+7.06%	$9.21	Q4 2023
9/30/2023	0%	+0%	$33.2M	2.01M	+231,303	+13%	$16.50	Q3 2023
6/30/2023	0%		$11.3M	1.78M	+1,900	+0.11%	$6.32	Q2 2023
3/31/2023	0%	0%	$6.04M	1.78M	-614,255	-25.7%	$3.40	Q1 2023
12/31/2022	0%	0%	$13.8M	2.39M	-619,655	-20.6%	$5.78	Q4 2022
9/30/2022	0%	+0%	$28.3M	3.01M	+53,565	+1.81%	$9.40	Q3 2022
6/30/2022	0%	+0%	$66M	2.96M	+30,412	+1.04%	$22.31	Q2 2022
3/31/2022	0%	+0%	$161M	2.93M	+23,393	+0.81%	$54.98	Q1 2022
12/31/2021	0%	+0%	$192M	2.91M	+20,232	+0.7%	$66.09	Q4 2021
9/30/2021	0.01%	+0%	$242M	2.88M	+23,253	+0.81%	$83.94	Q3 2021
6/30/2021	0.01%	+0%	$363M	2.86M	+127,044	+4.65%	$126.93	Q2 2021
3/31/2021	0.01%	+0%	$300M	2.73M	+897,770	+48.9%	$109.70	Q1 2021
12/31/2020	0.01%	+0%	$262M	1.84M	+504,805	+37.9%	$142.77	Q4 2020
9/30/2020	0%	+0%	$94M	1.33M	+48,504	+3.78%	$70.57	Q3 2020
6/30/2020	0%	+0%	$89.8M	1.28M	+212,351	+19.8%	$69.98	Q2 2020
3/31/2020	0%	+0%	$37.4M	1.07M	+28,284	+2.71%	$34.96	Q1 2020
12/31/2019	0%	+0%	$65.6M	1.04M	+79,332	+8.23%	$62.86	Q4 2019
9/30/2019	0%	+0%	$32.3M	963K	+208,335	+27.6%	$33.52	Q3 2019
6/30/2019	0%	+0%	$19.6M	755K	+238,211	+46.1%	$25.98	Q2 2019
3/31/2019	0%	+0%	$8.55M	517K	+19,343	+3.89%	$16.54	Q1 2019
12/31/2018	0%	+0%	$5.39M	498K	+92,376	+22.8%	$10.83	Q4 2018
9/30/2018	0%	+0%	$10.1M	405K	+138,224	+51.8%	$25.04	Q3 2018
6/30/2018	0%	+0%	$5.81M	267K	+83,343	+45.4%	$21.76	Q2 2018
3/31/2018	0%	+0%	$2.69M	184K	+183,635	NEW	$14.63	Q1 2018

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.